Works in Diabetes, Obesity & Metabolism, 2018, Vol 20, Issue 2

Results: 32

Cover Image, Volume 20, Issue 2.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. i, doi. 10.1111/dom.13195

By:

Seino, Yutaka;
Terauchi, Yasuo;
Osonoi, Takeshi;
Yabe, Daisuke;
Abe, Nobuyuki;
Nishida, Tomoyuki;
Zacho, Jeppe;
Kaneko, Shizuka

Publication type:

Article

Comparative effectiveness of once‐weekly glucagon‐like peptide‐1 receptor agonists with regard to 6‐month glycaemic control and weight outcomes in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 468, doi. 10.1111/dom.13107

By:

Unni, Sudhir;
Wittbrodt, Eric;
Ma, Junjie;
Schauerhamer, Marisa;
Hurd, Jeff;
Ruiz‐Negrón, Natalia;
McAdam‐Marx, Carrie

Publication type:

Article

Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 463, doi. 10.1111/dom.13104

By:

Aggarwal, Naresh;
Singla, Anuj;
Mathieu, Chantal;
Montanya, Eduard;
Pfeiffer, Andreas F. H.;
Johnsson, Eva;
Zhao, June;
Iqbal, Nayyar;
Bailey, Clifford

Publication type:

Article

Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 233, doi. 10.1111/dom.13102

By:

Nunez, Derek J.;
D'Alessio, David

Publication type:

Article

Effects of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trials.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 458, doi. 10.1111/dom.13101

By:

Zhao, Yumo;
Xu, Lubin;
Tian, Dongli;
Xia, Peng;
Zheng, Hua;
Wang, Li;
Chen, Limeng

Publication type:

Article

Diabetes, Obesity and Metabolism.

Published in:: Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 231, doi. 10.1111/dom.13090
Publication type:: Article

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 427, doi. 10.1111/dom.13088

By:

Khunti, Kamlesh;
Gomes, Marilia B.;
Pocock, Stuart;
Shestakova, Marina V.;
Pintat, Stéphane;
Fenici, Peter;
Hammar, Niklas;
Medina, Jesús

Publication type:

Article

Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 419, doi. 10.1111/dom.13087

By:

Johansen, Rakel F.;
Søndergaard, Esben;
Linnebjerg, Helle;
Garhyan, Parag;
Lam, Eric C. Q.;
Porksen, Niels;
Jacober, Scott J.;
Nielsen, Søren

Publication type:

Article

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 409, doi. 10.1111/dom.13086

By:

Gallwitz, Baptist;
Dagogo‐Jack, Samuel;
Thieu, Vivian;
Garcia‐Perez, Luis‐Emilio;
Pavo, Imre;
Yu, Maria;
Robertson, Kenneth E.;
Zhang, Nan;
Giorgino, Francesco

Publication type:

Article

Primary sulphonylurea therapy in a newborn with transient neonatal diabetes attributable to a paternal uniparental disomy 6q24 (UPD6).

Published in:

2018

By:

Neumann, Uta;
Bührer, Christoph;
Blankenstein, Oliver;
Kühnen, Peter;
Raile, Klemens

Publication type:

Case Study

Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK‐1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 400, doi. 10.1111/dom.13084

By:

Crutchlow, Michael F.;
Palcza, John S.;
Mostoller, Kate M.;
Mahon, Chantal D.;
Barbour, April M.;
Marcos, Michael C.;
Xu, Yang;
Watkins, Elaine;
Morrow, Linda;
Hompesch, Marcus

Publication type:

Article

Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 389, doi. 10.1111/dom.13083

By:

Khunti, Kamlesh;
Godec, Thomas R.;
Medina, Jesús;
Garcia‐Alvarez, Laura;
Hiller, Josh;
Gomes, Marilia B.;
Cid‐Ruzafa, Javier;
Charbonnel, Bernard;
Fenici, Peter;
Hammar, Niklas;
Hashigami, Kiyoshi;
Kosiborod, Mikhail;
Nicolucci, Antonio;
Shestakova, Marina V.;
Ji, Linong;
Pocock, Stuart

Publication type:

Article

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 378, doi. 10.1111/dom.13082

By:

Seino, Yutaka;
Terauchi, Yasuo;
Osonoi, Takeshi;
Yabe, Daisuke;
Abe, Nobuyuki;
Nishida, Tomoyuki;
Zacho, Jeppe;
Kaneko, Shizuka

Publication type:

Article

Sodium‐glucose cotransporter‐2 inhibition improves incretin sensitivity of pancreatic β‐cells in people with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 370, doi. 10.1111/dom.13081

By:

Ahn, Chang Ho;
Oh, Tae Jung;
Kwak, Soo Heon;
Cho, Young Min

Publication type:

Article

The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 362, doi. 10.1111/dom.13080

By:

Brønden, Andreas;
Albér, Anders;
Rohde, Ulrich;
Gasbjerg, Lærke S.;
Rehfeld, Jens F.;
Holst, Jens J.;
Vilsbøll, Tina;
Knop, Filip K.

Publication type:

Article

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 453, doi. 10.1111/dom.13079

By:

Kadowaki, Takashi;
Inagaki, Nobuya;
Kondo, Kazuoki;
Nishimura, Kenichi;
Kaneko, Genki;
Maruyama, Nobuko;
Nakanishi, Nobuhiro;
Gouda, Maki;
Iijima, Hiroaki;
Watanabe, Yumi

Publication type:

Article

Efficacy and pharmacokinetics of subcutaneous exendin (9‐39) in patients with post‐bariatric hypoglycaemia.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 352, doi. 10.1111/dom.13078

By:

Craig, Colleen M.;
Liu, Li‐fen;
Nguyen, Thi;
Price, Candice;
Bingham, Justus;
McLaughlin, Tracey L.

Publication type:

Article

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 344, doi. 10.1111/dom.13077

By:

Persson, Frederik;
Nyström, Thomas;
Jørgensen, Marit E.;
Carstensen, Bendix;
Gulseth, Hanne L.;
Thuresson, Marcus;
Fenici, Peter;
Nathanson, David;
Eriksson, Jan W.;
Norhammar, Anna;
Bodegard, Johan;
Birkeland, Kåre I.

Publication type:

Article

A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 283, doi. 10.1111/dom.13075

By:

Kostic, Ana;
King, Thomas Alexander;
Yang, Feng;
Chan, Kuo‐Chen;
Yancopoulos, George D.;
Gromada, Jesper;
Harp, Joyce B.

Publication type:

Article

Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 335, doi. 10.1111/dom.13072

By:

Yang, Wenying;
Min, Kyungwan;
Zhou, Zhiguang;
Li, Ling;
Xu, XiangJin;
Zhu, Dalong;
Venkateshwar Rao, A.;
Murthy, Laxminarayanappa Sreenivasa;
Zhang, Nianxian;
Li, Ivy;
Niemoeller, Elisabeth;
Shang, Shuhua

Publication type:

Article

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 448, doi. 10.1111/dom.13071

By:

Roussel, Ronan;
d'Emden, Michael C.;
Fisher, Miles;
Ampudia‐Blasco, F. Javier;
Stella, Peter;
Bizet, Florence;
Cali, Anna M. G.;
Wysham, Carol H.

Publication type:

Article

PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 270, doi. 10.1111/dom.13070

By:

Page, Michael M.;
Watts, Gerald F.

Publication type:

Article

Evaluation of the specific effects of intranasal glucagon on glucose production and lipid concentration in healthy men during a pancreatic clamp.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 328, doi. 10.1111/dom.13069

By:

Dash, Satya;
Xiao, Changting;
Stahel, Priska;
Koulajian, Khajag;
Giacca, Adria;
Lewis, Gary F.

Publication type:

Article

Beneficial long‐term antidiabetic actions of N‐ and C‐terminally modified analogues of apelin‐13 in diet‐induced obese diabetic mice.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 319, doi. 10.1111/dom.13068

By:

Parthsarathy, Vadivel;
Hogg, Christopher;
Flatt, Peter R.;
O'Harte, Finbarr P. M.

Publication type:

Article

Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population‐based retrospective cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 309, doi. 10.1111/dom.13066

By:

Wan, Eric Yuk Fai;
Fong, Daniel Yee Tak;
Fung, Colman Siu Cheung;
Yu, Esther Yee Tak;
Chin, Weng Yee;
Chan, Anca Ka Chun;
Lam, Cindy Lo Kuen

Publication type:

Article

The effect of exercise on sleep in adults with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 443, doi. 10.1111/dom.13065

By:

Reddy, Ravi;
El Youssef, Joseph;
Winters‐Stone, Kerri;
Branigan, Deborah;
Leitschuh, Joseph;
Castle, Jessica;
Jacobs, Peter G.

Publication type:

Article

Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 301, doi. 10.1111/dom.13064

By:

Berard, Lori;
Bonnemaire, Mireille;
Mical, Marie;
Edelman, Steve

Publication type:

Article

Therapeutic application of GPR119 ligands in metabolic disorders.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 257, doi. 10.1111/dom.13062

By:

Yang, Jin Won;
Kim, Hyo Seon;
Choi, Yong‐Won;
Kim, Young‐Mi;
Kang, Keon Wook

Publication type:

Article

Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective randomized controlled pilot study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 438, doi. 10.1111/dom.13061

By:

Shibuya, Takashi;
Fushimi, Nobutoshi;
Kawai, Miyuka;
Yoshida, Yohei;
Hachiya, Hiroki;
Ito, Shun;
Kawai, Hiromi;
Ohashi, Noritsugu;
Mori, Akihiro

Publication type:

Article

Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 292, doi. 10.1111/dom.13059

By:

Han, Sang Youb;
Yoon, Sun Ae;
Han, Byoung Geun;
Kim, Sung Gyun;
Jo, Young‐Il;
Jeong, Kyung Hwan;
Oh, Kook‐Hwan;
Park, Hyeong Cheon;
Park, Sun‐Hee;
Kang, Shin‐Wook;
Na, Ki‐Ryang;
Kang, Sun Woo;
Kim, Nam‐Ho;
Jang, Younghwan;
Kim, Bogyeong;
Shin, Seonghye;
Cha, Dae Ryong

Publication type:

Article

The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 245, doi. 10.1111/dom.13052

By:

Gingras, Véronique;
Taleb, Nadine;
Roy‐Fleming, Amélie;
Legault, Laurent;
Rabasa‐Lhoret, Rémi

Publication type:

Article

Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventions.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 238, doi. 10.1111/dom.13033

By:

Roussel, Ronan;
Steg, Philippe Gabriel;
Mohammedi, Kamel;
Marre, Michel;
Potier, Louis

Publication type:

Article